통증 관리 치료 시장 규모, 점유율, 성장 분석 : 약제 클래스별, 적응증별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Pain Management Therapeutics Market Size, Share, Growth Analysis, By Drug Class (NSAIDs, Anesthetics), By Indication (Arthritic Pain, Neuropathic Pain), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1630740
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 276 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 통증 관리 치료 시장 규모는 2023년에 787억 달러로 평가되며, 예측 기간 중(2025-2032년) CAGR 3.6%로 성장하며, 2024년 815억 3,000만 달러에서 2032년에는 1,082억 달러로 성장할 전망입니다.
2023년 10월 현재, 통증 관리의 상황은 의료 분야에서 통증 관리의 중요성에 대한 인식이 높아진 것을 반영하고 있습니다. 섬유근육통, 신경병증성 통증, 수술 후 불편감 등 만성적인 증상을 포함한 다양한 유형의 통증에 대해 환자의 QOL을 향상시키는 다학제적 접근법을 시행하기 위해 통증의학 전문의에게 의존하는 의사가 증가하고 있습니다. 통증 관리 치료의 인기가 높아지는 것은 다양한 의료 문제에 대응하고 있다는 점에서 분명합니다. 그러나 정부 예산 삭감 및 제약사 스폰서의 지원 감소로 인해 통증 옹호 단체의 영향력과 재원이 감소함에 따라 시장은 문제에 직면해 있습니다. 이러한 단체들은 역사적으로 통증 관리 구상을 추진하는 데 중요한 역할을 해왔기 때문에 이러한 추세는 시장 성장에 잠재적인 장애물이 될 수 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술 분석
특허 분석
통증 관리 치료 시장 규모 : 약제 클래스별
시장 개요
NSAIDs
마취제
항경련약
편두통 치료제
항우울제
오피오이드
비마약성 진통제
기타
통증 관리 치료 시장 규모 : 적응증별
시장 개요
관절염 통증
신경병증성 통증
암 통증
만성 요통
수술후 통증
편두통
섬유근육통
근육 염좌
골절
급성 맹장염
기타
통증 관리 치료 시장 규모 : 유통 채널별
시장 개요
온라인 약국
병원 약국
소매 약국
통증 관리 치료 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
CSL Behring(Australia)
Takeda Pharmaceutical Company Limited(Japan)
Pharming Group N.V.(Netherlands)
BioCryst Pharmaceuticals, Inc.(USA)
Ionis Pharmaceuticals, Inc.(USA)
Sanofi S.A.(France)
Adverum Biotechnologies, Inc.(USA)
KalVista Pharmaceuticals, Inc.(USA)
Attune Pharmaceuticals, Inc.(USA)
Arrowhead Pharmaceuticals, Inc.(USA)
Amgen Inc.(USA)
BioMarin Pharmaceutical Inc.(USA)
Catalyst Biosciences, Inc.(USA)
RUCONEST(Pharming Group N.V., Netherlands)
Haegarda(CSL Limited, Australia)
Firazyr(Shire plc, UK)
Shire plc(UK)
Dyax Corp.(USA)
Adverum Biotechnologies, Inc.(USA)
Amgen Inc.(USA)
결론과 권장사항
KSA
영문 목차
영문목차
Global Pain Management Therapeutics Market size was valued at USD 78.7 billion in 2023 and is poised to grow from USD 81.53 billion in 2024 to USD 108.2 billion by 2032, growing at a CAGR of 3.6% during the forecast period (2025-2032).
As of October 2023, the landscape of pain management reflects a growing recognition of its importance within the medical field. Physicians increasingly turn to pain medicine specialists to implement multidisciplinary approaches that enhance patient quality of life across various types of pain, including chronic conditions like fibromyalgia, neuropathic pain, and post-operative discomfort. The rising popularity of pain management therapeutics is evident as they cater to a wide spectrum of medical issues. However, the market faces challenges as pain advocacy organizations experience diminishing influence and financial resources due to government funding cuts and decreased support from pharmaceutical sponsors. This trend poses a potential hurdle for market growth as these organizations have historically played a crucial role in advancing pain management initiatives.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pain Management Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pain Management Therapeutics Market Segmental Analysis
Global Pain Management Therapeutics Market is segmented by Drug Class, Indication, Distribution channel and region. Based on Drug Class, the market is segmented into NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics and Others. Based on Indication, the market is segmented into Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain/Strain, Bone Fracture, Acute Appendicitis and Others. Based on Distribution channel, the market is segmented into Online Pharmacy, Hospital Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pain Management Therapeutics Market
The global pain management therapeutics market is experiencing significant growth due to the increasing prevalence of various medical conditions that lead to pain and discomfort, such as ulcers, osteoarthritis, chronic arthritis, multiple sclerosis, cancer, and diabetic neuropathy. These conditions necessitate effective treatments for both acute and chronic pain, driving demand for pain management solutions. As patients seek relief from their ailments, the preference for advanced pain management therapeutics rises, further fueling market expansion. Consequently, the collective urgency to address pain-related issues across diverse populations is a crucial factor contributing to the market's robust development.
Restraints in the Global Pain Management Therapeutics Market
The growth of the Global Pain Management Therapeutics market is anticipated to be hindered by the issue of prescription drug abuse. Many individuals consume prescribed medications in a manner that deviates from medical guidance, often underestimating the potential dangers associated with such behavior. This misuse not only poses significant health risks but can also result in severe consequences, including fatal outcomes. As awareness of these dangers increases, it may lead to stricter regulations and more cautious prescribing practices, ultimately curbing the expansion of the market. Consequently, addressing the challenges posed by prescription misuse is crucial for sustainable market growth.
Market Trends of the Global Pain Management Therapeutics Market
The Global Pain Management Therapeutics market is witnessing a significant trend towards personalized medicine, with a growing focus on biologics and rapid-acting lifestyle therapies, which currently represent over 70% of all medications under development. This shift is driven by advancements in pharmacogenomics and an increased understanding of individual pain mechanisms, leading to targeted treatments that enhance efficacy and reduce side effects. Additionally, the rising prevalence of chronic pain conditions and a growing aging population are fueling demand for innovative therapies, positioning personalized approaches as a key driver in the evolution of pain management strategies globally.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Patent Analysis
Global Pain Management Therapeutics Market Size by Drug Class & CAGR (2025-2032)
Market Overview
NSAIDs
Anesthetics
Anticonvulsants
Anti-migraine Agents
Antidepressants
Opioids
Nonnarcotic Analgesics
Others
Global Pain Management Therapeutics Market Size by Indication & CAGR (2025-2032)
Market Overview
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Back Pain
Postoperative Pain
Migraine
Fibromyalgia
Muscle Sprain/Strain
Bone Fracture
Acute Appendicitis
Others
Global Pain Management Therapeutics Market Size by Distribution channel & CAGR (2025-2032)
Market Overview
Online Pharmacy
Hospital Pharmacy
Retail Pharmacy
Global Pain Management Therapeutics Market Size & CAGR (2025-2032)
North America (Drug Class, Indication, Distribution channel)
US
Canada
Europe (Drug Class, Indication, Distribution channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Drug Class, Indication, Distribution channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Drug Class, Indication, Distribution channel)
Brazil
Rest of Latin America
Middle East & Africa (Drug Class, Indication, Distribution channel)
